2024 annual financial data
MoonLake Immunotherapeutics 2024 Operating margin
MoonLake Immunotherapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -143,091,082 USD and net income was -118,935,517 USD.
Operating cash flow was -116,587,263 USD.
Get free MoonLake Immunotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -143,091,082 USD
- Net income
- -118,935,517 USD
- Operating cash flow
- -116,587,263 USD
Explore related company data
View all 2024 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Net marginView Operating cash flow marginView all MoonLake Immunotherapeutics financial years